Early initiation of anti-TNF therapy in psoriatic arthritis (PsA) almost doubles the rate of remission and challenges the classical step-up approach to therapy, according to a study from the Netherlands. The study randomised 51 patients with a median duration of disease of 0.5 years to either a combination of methotrexate (25 mg/wk) with golimumab (50mg ...
Early initiation of biologic doubles remission rate in PsA
By Mardi Chapman
5 Mar 2019